Cellosaurus cell line KTOR3 (CVCL

Entry history
Cell line name	KTOR3
Accession	CVCL_E6DA
Resource Identification Initiative	To cite this cell line use: KTOR3 (RRID:CVCL_E6DA)
Comments	Population: Japanese. Doubling time: 164.5 hours (PubMed=31900393). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations	Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
Disease	Lung non-small cell carcinoma (NCIt: C2926)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Male
Age at sampling	31Y
Category	Cancer cell line
Publications	PubMed=31900393; DOI=10.1038/s41467-019-13771-5; PMCID=PMC6941996 Tsuji T., Ozasa H., Aoki W., Aburaya S., Yamamoto Funazo T., Furugaki K., Yoshimura Y., Yamazoe M., Ajimizu H., Yasuda Y., Nomizo T., Yoshida H., Sakamori Y., Wake H., Ueda M., Kim Y.H., Hirai T. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nat. Commun. 11:74.1-74.16(2020)
Entry creation	10-Apr-2025
Last entry update	10-Apr-2025
Version number	1